Chronic graft-versus-host disease (GVHD) is a major limitation of successful allogeneic
hematopoietic stem cell transplantation (HSCT). Extracorporeal photochemotherapy (ECP) …

Graft‐versus‐host disease (GVHD) occurs in a number of clinical settings. It is well
recognized after bone marrow transplantation, an increasingly used therapeutic option for …

With reference to the paper by Child et al1 entitled 'Extracorporeal photopheresis (ECP) in
the treatment of chronic graft-versus-host disease (GVHD)', published in your journal we …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

Chronic graft‐versus‐host disease (GvHD) affects 50% of long‐term bone marrow transplant
survivors and remains a cause of major long‐term morbidity in these patients despite …

The treatment of cutaneous graft‐versus‐host disease (GVHD) is one of the most
challenging clinical scenarios in a dermatological practice. Given the significant risk of …

Acute graft-versus-host disease (aGVHD) is a frequent and major complication after
allogeneic stem cell transplantation. For many years psoralen and ultraviolet (UV)-A light …

Chronic graft-versus-host disease (GVHD) remains a difficult clinical problem to treat and
manage. We have reviewed our treatment of 40 patients treated at a single institution with …

BACKGROUND: Acute graft-versus-host disease (aGvHD) is a common complication of
allogeneic stem cell transplantation. It is usually treated with high doses of corticosteroids …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …